# OnCo record amply-discovery (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/amply-discovery/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "amply-discovery" ;
  schema:name "AMPLY Discovery"@en ;
  schema:alternateName "AMPLY"@en ;
  schema:description "AMPLY Discovery is a Belfast company that uses its own AI platform to find new switches in the genome that cancers depend on, and then designs RNA medicines to turn them off. Its first targets are in triple-negative breast cancer and ovarian cancer."@en ;
  schema:url <https://onco.cc/companies/amply-discovery/>, <https://www.amplydiscovery.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.amplydiscovery.com/>, <https://techfundingnews.com/ai-drug-discovery-startup-amply-secures-seed-funding/> ;
  schema:addressCountry "GB" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/high-grade-serous-ovarian-cancer/> ;
  onco:sections <https://onco.cc/fronts/drug-discovery/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:technologies <https://onco.cc/technologies/ai-drug-design/> .